INTECH Investment Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.07M Sell
20,871
-2,643
-11% -$548K 0.04% 439
2026
Q1
$5.28M Sell
23,514
-44,215
-65% -$11M 0.05% 325
2025
Q4
$16.3M Buy
67,729
+36,430
+116% +$9.32M 0.15% 115
2025
Q3
$8.57M Buy
31,299
+9,083
+41% +$2.48M 0.08% 225
2025
Q2
$5.73M Buy
22,216
+6,891
+45% +$1.64M 0.05% 316
2025
Q1
$3.43M Buy
15,325
+5,934
+63% +$1.39M 0.04% 457
2024
Q4
$2.15M Buy
9,391
+8,391
+839% +$2.02M 0.02% 677
2024
Q3
$244K Buy
+1,000
New +$223K ﹤0.01% 1628
2024
Q1
Sell
-5,885
Closed -$1.01M 747
2023
Q4
$1.01M Sell
5,885
-2,864
-33% -$440K 0.01% 426
2023
Q3
$1.29M Sell
8,749
-10,022
-53% -$1.81M 0.02% 405
2023
Q2
$4.1M Sell
18,771
-37,163
-66% -$8.28M 0.04% 299
2023
Q1
$12.2M Sell
55,934
-74,972
-57% -$16.3M 0.1% 252
2022
Q4
$27.2M Sell
130,906
-106,887
-45% -$23.5M 0.2% 143
2022
Q3
$51.9M Sell
237,793
-426,153
-64% -$97M 0.39% 60
2022
Q2
$139M Buy
+663,946
New +$141M 0.8% 19

Other funds holding RMD

INTECH Investment Management's RMD Position: Q2 2026 in Review

INTECH Investment Management reduced its ResMed (RMD) stake by 11% in Q2 2026, selling an estimated $548K and leaving 20,871 shares worth $4.07M. The position accounts for 0.04% of the portfolio, ranked #439.

INTECH Investment Management first reported a position in RMD in Q2 2022 and has held it in 15 quarters since. The position peaked at $139M in Q2 2022. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • INTECH Investment Management held 20,871 shares of ResMed worth $4.07M as of Q2 2026.
  • INTECH Investment Management sold 2,643 ResMed shares in Q2 2026, an estimated $548K.
  • ResMed made up 0.04% of INTECH Investment Management's portfolio in Q2 2026, its #439 holding.
  • INTECH Investment Management first reported a position in ResMed in Q2 2022 and has held it in 15 quarters since.
  • INTECH Investment Management's ResMed position peaked at $139M in Q2 2022.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.